INM
Price:
$0.243
Market Cap:
$3.24M
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosyn...[Read more]
Industry
Biotechnology
IPO Date
2014-05-05
Stock Exchange
NASDAQ
Ticker
INM
According to InMed Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of InMed Pharmaceuticals Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), INM's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of InMed Pharmaceuticals Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2024 | 0% | 0% |
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
The current Dividend Yield of InMed Pharmaceuticals Inc. (INM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
InMed Pharmaceuticals Inc.’s Dividend Yield is less than Quoin Pharmaceuticals, Ltd. (0%), less than Allarity Therapeutics, Inc. (0%), less than Kiromic BioPharma, Inc. (0%), less than Virax Biolabs Group Limited (0%), less than Biodexa Pharmaceuticals Plc (0%), less than SeaStar Medical Holding Corporation (0%), less than Virios Therapeutics, Inc. (0%), less than ZyVersa Therapeutics, Inc. (0%), less than Sonnet BioTherapeutics Holdings, Inc. (0%), less than Revelation Biosciences, Inc. (0%), less than Palisade Bio, Inc. (0%), less than Bright Minds Biosciences Inc. (0%), less than Tonix Pharmaceuticals Holding Corp. (0%), less than Immix Biopharma, Inc. (0%), less than Phio Pharmaceuticals Corp. (0%), less than 180 Life Sciences Corp. (0%), less than Navidea Biopharmaceuticals, Inc. (0%), less than Sigilon Therapeutics, Inc. (0%), less than NovaBay Pharmaceuticals, Inc. (0%), less than GeoVax Labs, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $2.86M | |
0% | $1.99M | |
0% | $1.73M | |
0% | $8.86M | |
0% | $3.30M | |
0% | $12.30M | |
0% | $206.50K | |
0% | $1.96M | |
0% | $2.96M | |
0% | $3.19M | |
0% | $3.70M | |
0% | $225.83M | |
0% | $19.46M | |
0% | $43.37M | |
0% | $2.76M | |
0% | $3.51M | |
0% | $50.04K | |
0% | $56.22M | |
0% | $3.69M | |
0% | $15.26M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InMed Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InMed Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is InMed Pharmaceuticals Inc.'s Dividend Yield?
How is the Dividend Yield calculated for InMed Pharmaceuticals Inc. (INM)?
What is the highest Dividend Yield for InMed Pharmaceuticals Inc. (INM)?
What is the 3-year average Dividend Yield for InMed Pharmaceuticals Inc. (INM)?
What is the 5-year average Dividend Yield for InMed Pharmaceuticals Inc. (INM)?
How does the current Dividend Yield for InMed Pharmaceuticals Inc. (INM) compare to its historical average?